BREAKTHROUGH IN THE MANAGEMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION: A NATIONWIDE STUDY - Individual Prediction and Prevention of Risks of Immunosuppressive Therapies in Transplantation Access content directly
Conference Papers Year : 2017

BREAKTHROUGH IN THE MANAGEMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION: A NATIONWIDE STUDY

Philippe Gatault
Noemie Jourde-Chiche
  • Function : Author
  • PersonId : 1064169
Raphaël Gaisne
  • Function : Author
Lionel Couzi
  • Function : Author
  • PersonId : 951011
Rebecca Sberro-Soussan
  • Function : Author
Mayvonne Hourmant
  • Function : Author
C. Pouteil-Noble
  • Function : Author
Éric Rondeau
  • Function : Author
No file

Dates and versions

hal-01787228 , version 1 (07-05-2018)

Identifiers

  • HAL Id : hal-01787228 , version 1

Cite

Julien Zuber, Nassim Kamar, Marie Frimat, Moglie Le Quintrec, Philippe Gatault, et al.. BREAKTHROUGH IN THE MANAGEMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION: A NATIONWIDE STUDY. European Society for Organ Transplantation Congress 2017, Sep 2017, BARCELONE, Spain. ⟨hal-01787228⟩
101 View
0 Download

Share

Gmail Facebook X LinkedIn More